Corresponding Responsibility: Cash Oxycodone and Alprazolam From 90 Miles Away
A 32-year-old man new to the pharmacy presents two prescriptions from a prescriber 90 miles away in another county: oxycodone 30 mg, quantity 120, one tablet four times daily, and alprazolam 2 mg, quantity 90, one tablet three times daily. He pays cash and says he is 'in town for work.' The Oregon PDMP shows an oxycodone 30 mg fill 18 days ago at another pharmacy, a hydrocodone fill 40 days ago from a different prescriber, and alprazolam from a third prescriber. The patient is drowsy, has pinpoint pupils, and says he took 'a couple' of a friend's oxycodone earlier. The prescriber's office is closed and the pharmacist reaches only an answering machine. The patient becomes impatient and says, 'You have to fill it; it's legal.'
1. May the pharmacist fill either prescription today? Apply federal corresponding responsibility and Oregon PDMP information.
Read the worked answer
No. Under the federal Controlled Substances Act and 21 CFR 1306.04, a prescription for a controlled substance must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice. The pharmacist has a corresponding responsibility not to fill a prescription when red flags are present and unresolved. Here the red flags include cash payment, travel from 90 miles away, an early oxycodone refill, multiple prescribers and pharmacies in the PDMP, overlapping opioid and benzodiazepine therapy, and objective signs of sedation and pinpoint pupils. The patient's statement that he took a friend's oxycodone adds a safety concern. The pharmacist cannot verify the prescriptions with the prescriber because the office is closed. A legal-looking prescription is not enough; the pharmacist must resolve the red flags before dispensing. Filling now would violate the corresponding-responsibility standard and could harm the patient.
2. What verification and documentation steps should the pharmacist take before making a final decision?
Read the worked answer
The pharmacist should review the Oregon PDMP in detail, including dates, quantities, prescribers, and pharmacies, and should try alternative contact numbers for the prescriber. The pharmacist should ask the patient about the current prescriptions, the earlier fills, the friend's oxycodone, and symptoms of overdose or withdrawal. Because the patient is drowsy with pinpoint pupils, the pharmacist should assess for acute opioid toxicity and call emergency services if overdose is suspected. The pharmacist should not simply accept the patient's explanation that the prescription is legal. If the prescriber cannot be reached, the pharmacist should document the red flags, the PDMP review, the patient interview, the failed verification attempts, and the decision not to fill. The pharmacist should also document any naloxone offered and any referral for emergency care. Documentation protects the patient and shows that the pharmacist exercised corresponding responsibility rather than refusing arbitrarily.
3. If the pharmacist refuses to fill, what may and may not the pharmacist do with the prescriptions and the patient?
Read the worked answer
The pharmacist may decline to fill and should explain briefly that the prescriptions cannot be verified safely today. The pharmacist must not confiscate the prescriptions; they are the patient's property, and the pharmacist should return them if the patient asks. The pharmacist should not accuse the patient of a crime or discuss the PDMP in front of other patients. The pharmacist should offer naloxone and overdose education, and should encourage the patient to seek urgent care if he feels sedated or unwell. The pharmacist may contact the prescriber during business hours to discuss the concerns and may report suspected diversion or prescribing problems to the Oregon Board of Pharmacy or other appropriate authority if the facts support it. The pharmacist should document the refusal, the return of the prescriptions, the naloxone offer, and any referral. The pharmacist should not tell the patient to 'just go somewhere else,' which could facilitate unsafe use.